Sanjeev Sethi (@sethirenalpath) 's Twitter Profile
Sanjeev Sethi

@sethirenalpath

Professor, Pathology, Mayo Clinic, MN. 💯 clinical. Renal pathology. Use X to teach, clinical info changed=protect confidentiality. Love dogs. Views are my own.

ID: 950068456996720647

linkhttps://scholar.google.ca/citations?user=gR5VghIAAAAJ&hl=en calendar_today07-01-2018 18:15:46

1,1K Tweet

13,13K Takipçi

155 Takip Edilen

Mayo Clinic Labs (@mayocliniclabs) 's Twitter Profile Photo

Membranous nephropathy is an autoimmune disease that damages blood vessels in the kidneys. Our mass spectrometry test identifies 13 antigens known to cause the disease. Learn more in this test-specific "Answers From the Lab" podcast with Sanjeev Sethi. bit.ly/425FfZX

Membranous nephropathy is an autoimmune disease that damages blood vessels in the kidneys. Our mass spectrometry test identifies 13 antigens known to cause the disease.

Learn more in this test-specific "Answers From the Lab" podcast with <a href="/SethiRenalPath/">Sanjeev Sethi</a>.
bit.ly/425FfZX
Sam Albadri, M.D., M.Sc. (@sam_albadri) 's Twitter Profile Photo

Interested in renal pathology? Apply now for the 2026–2027 Renal Pathology Fellowship Mayo Clinic Pathology Rochester—world-class faculty, diverse case volume, cutting-edge research opportunities Priya Alexander, MD Renal Pathology Society Sanjeev Sethi Learn more&apply: college.mayo.edu/academics/resi…

Sanjeev Sethi (@sethirenalpath) 's Twitter Profile Photo

A lovely sketch made by Dr. Estela Mas Rodenas. Look carefully and you can see the Mayo Clinic in the picture. Thank you very much for the beautiful sketch. It was wonderful having you train with us. Safe travels back to Mallorca. Estela Mas Ródenas

A lovely sketch made by Dr. Estela Mas Rodenas. Look carefully and you can see the <a href="/MayoClinic/">Mayo Clinic</a> in the picture. 

Thank you very much for the beautiful sketch. It was wonderful having you train with us. Safe travels back to Mallorca. <a href="/EstelaNefro/">Estela Mas Ródenas</a>
Sanjeev Sethi (@sethirenalpath) 's Twitter Profile Photo

This Dx often not the mind of nephrologist- always surprised by Dx Fibrillary Glomerulonephritis LM: Membranoproliferative GN IF: IgG 3+, polyclonal=3+ kappa & lambda EM: fibrillary deposits DNAJB9 positive, Congo red negative 65 yr obese lady, hematuria & proteinuria. Cr 2

This Dx often not the mind of nephrologist- always surprised by Dx

Fibrillary Glomerulonephritis

LM: Membranoproliferative GN
IF: IgG 3+, polyclonal=3+ kappa &amp; lambda 
EM: fibrillary deposits

DNAJB9 positive, Congo red negative 

65 yr obese lady, hematuria &amp; proteinuria. Cr 2
fernando fervenza (@fervenzafernan1) 's Twitter Profile Photo

Many people tried to prevent publication of this data. Puts to rest claims that we don’t have hard-end points in MN treated with RTX! Long-term Outcome of Adult Patients with Membranous Nephropathy treated with Rituximab. - Kidney International Reports kireports.org/article/S2468-…

Sanjeev Sethi (@sethirenalpath) 's Twitter Profile Photo

Gian Marco- It was wonderful having you train with us. Seven months went by quickly-you were at every renal pathology sign out with me. You never missed my weekend sign out taking every opportunity to learn. Wish you all the best for your future. Safe travels to Bologna 🇮🇹

Gian Marco- It was wonderful having you train with us. Seven months went by quickly-you were at every renal pathology sign out with me. You never missed my weekend sign out taking every opportunity to learn. 

Wish you all the best for your future.
Safe travels to Bologna 🇮🇹
Andrea Angioi, MD, FASN (@andreaangioi) 's Twitter Profile Photo

🌍 ERA Congress 2025 – Vienna 🧠 Focus: Membranous Nephropathy An inspiring session chaired by Ingeborg Bajema & Michael Rudnicki. Sanjeev Sethi speaking on MGN. From anti-PLA2R to the promise of epitope-specific assays, from pathology to patient: the conversation is evolving.

🌍 ERA Congress 2025 – Vienna
🧠 Focus: Membranous Nephropathy

An inspiring session chaired by Ingeborg Bajema &amp; Michael Rudnicki.

Sanjeev Sethi speaking on MGN.

From anti-PLA2R to the promise of epitope-specific assays, from pathology to patient: the conversation is evolving.